Nanoparticles deliver brain cancer treatment: University of Queensland researchers have developed a nanoparticle to take a chemotherapy drug into fast growing, aggressive brain tumours. Research team lead Dr Taskeen Janjua from UQ’s School of Pharmacy said the new silica nanoparticle can be loaded with temozolomide, a small molecule drug used to treat tumours known as […]
Read More… from Nanoparticles deliver brain cancer treatment
The 16th annual International Brain Tumour Awareness Week runs from Saturday 29th October to Saturday 5th November this year. The week is an opportunity to raise awareness of the symptoms and impacts of a brain tumour, and to campaign for more research to drive change in the treatments offered. The week also aims to encourage […]
A non-invasive Brain Cancer Treatment has been announced by Ivy Brain Tumor Center, SonALAsense and Insightec: The First Patient Dosed in First-in-Human Clinical Trial of Non-invasive Sonodynamic Therapy for the Treatment of Brain Cancer. The study combines metabolic targeting of glioblastoma with inert drug activated using MRI-guided focused ultrasound. The Ivy Brain Tumor Center at […]
Read More… from Non-invasive brain cancer treatment targeting glioblastoma
The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, has announced the dosing of its first patient in a first-in-human Phase 0 clinical trial of sonodynamic therapy (SDT), a non invasive drug-device combination developed by SonALAsense in collaboration with Insightec. This historic study aims to develop […]
Read More… from First Patient in Historic First-in-Human Clinical Trial for Glioblastoma